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CASE REPORT
Rhino-orbito-cerebral 
mucormycosis
Igor Teixeira Raymundo1, Beatriz Gonzalez De Araújo2, 
Carina De Carvalho Costa3, Joana Pinho Tavares4, 
Cleyverton Garcia Lima5, Luiz Augusto Nascimento6
INTRODUCTION
Mucormycosis is the most lethal 
fungal infection in humans and it is mani-
fested as a quick, progressive and invasive 
sinusitis. It usually affects immunocompro-
mized patients. Mortality is high, despite 
early diagnosis.1,2
We hereby present a severe case 
of a child with rhino-orbital-cerebral mu-
cormycosis; however with a very favorable 
outcome after aggressive treatment.
CASE PRESENTATION
A 12-year-old female patient started 
with sudden abdominal pain, polyuria, 
polydipsia, anorexia and a drop in cons-
cience level. She was diagnosed with 
untreated type I diabetes mellitus (diabetic 
acidosis), with blood sugar of 508 mg/dl 
upon hospital admission. After one week 
in the hospital, she started having eyelid 
ptosis, facial pain, converging strabismus, 
left side epistaxis and a progressive wor-
sening of her general health.
Skull and paranasal sinuses CT scan 
and MRI showed a soft tissue mass in the 
left nasal cavity, invading the ethmoidal, 
maxillary and cavernous sinuses and the 
ipsilateral orbit (Figure 1).
An endoscopic-guided tumor biop-
sy showed mucormycosis. The patient was 
started in high doses of endovenous am-
phothericin B liposome for 45 days. There 
was a mild improvement only. Anterior 
rhinoscopy showed a large brown-greenish 
mass occupying the entire left nasal cavity.
We decided to do a nasosinusal 
endoscopic exploration. During the proce-
dure we noticed a large mass coming from 
the maxillary sinus and the left nasal cavity. 
We did an exhaustive surgical debridement 
and cleaning in the maxillary, ethmoidal 
and sphenoidal sinuses with hypertonic 
saline solution, and we also flushed the 
region with an amphothericin B solution. 
Histology revealed a zygomycosis by Mu-
cor genus fungi.
The patient had a favorable outco-
me and returned in one week for a review. 
Upon anterior rhinoscopy, we noticed a 
fungal mass. A new CT scan suggested 
tumor recurrence. The patient was then 
submitted to 29 daily sessions of oxygen 
therapy in a hyperbaric chamber and the 
amphothericin B was exchanged for intra-
venous itraconazole because of the long 
term use of the former, and she was also 
submitted to a rigorous diabetic control.
There was a mild improvement 
and stability on her condition, leading us 
to choose to do a second look endoscopic 
exploration. The left nasal cavity was broad 
and clear, without any evidence of infec-
tion. The maxillary sinus ostium was open 
and there were no signs of mucormycosis.
The patient was discharged from 
the hospital in a stable condition and using 
oral itraconazole. The endoscopic view 
confirmed disease clearance. 
She is currently asymptomatic. Her 
capillary glucose is strictly controlled. She 
has nerve palsy of the III and IV cranial 
nerves on the left, however with good 
visual acuity and no diplopia.
DISCUSSION
Mucormycosis or zygomycosis is 
a rare opportunistic disease caused by 
Mucorales fungi, which belong to the geni 
Mucor, Rhizopus, Rhizomucor, Absidia 
and Apophysomyces. The most virulent 
and frequent species is Rhizopus oryzae, 
which invades and clogs blood vessels, 
causing tissue schemia.1,2 This disease can 
manifest itself in different clinical signs and 
symptoms, and the rhino-orbit-cerebral 
zygomycosis is the most severe form, ma-
nifesting itself usually in cases of diabetes 
mellitus of difficult control.3
Transmission is presumably throu-
gh the inhalation pathway.
Many clinical conditions are asso-
ciated with mucormycosis, but there are 
only two factors clearly associated with 
predisposing patients to the disease. The 
first is metabolic acidosis, and the second 
is disorders of neutrophils and monocytes.4
As a general rule, mucormycosis 
treatment is multimodal and includes the 
use of systemic antifungal drugs, surgical 
debridement and clinical control of the 
condition which is predisposing the patient 
to the disease.3
FINAL REMARKS
Proper Rhino-Orbit-Cerebral Mu-
cormycosis control includes early diag-
nosis, baseline disease control, treatment 
with antifungal systemic agents, proper 
sinus and orbital drainage and excision 
of the necrotic tissue, besides hyperbaric 
oxygen therapy.5
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Figure 1. Soft tissue tumor occupying the left nasal cavity and 
invading the cavernous sinus.
